天堂网亚洲,天天操天天搞,91视频高清,菠萝蜜视频在线观看入口,美女视频性感美女视频,95丝袜美女视频国产,超高清美女视频图片

Home Cart 0 Sign in  

[ CAS No. 610794-15-5 ] {[proInfo.proName]}

,{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]}
Chemical Structure| 610794-15-5
Chemical Structure| 610794-15-5
Structure of 610794-15-5 * Storage: {[proInfo.prStorage]}

Please Login or Create an Account to: See VIP prices and availability

Cart0 Add to My Favorites Add to My Favorites Bulk Inquiry Inquiry Add To Cart

Search after Editing

* Storage: {[proInfo.prStorage]}

* Shipping: {[proInfo.prShipping]}

Quality Control of [ 610794-15-5 ]

Related Doc. of [ 610794-15-5 ]

Alternatived Products of [ 610794-15-5 ]
Product Citations

Product Details of [ 610794-15-5 ]

CAS No. :610794-15-5 MDL No. :MFCD11878622
Formula : C9H8BrN Boiling Point : No data available
Linear Structure Formula :- InChI Key :DVCLJDAZHYRZHZ-UHFFFAOYSA-N
M.W : 210.07 Pubchem ID :10488635
Synonyms :

Calculated chemistry of [ 610794-15-5 ]      Expand+

Physicochemical Properties

Num. heavy atoms : 11
Num. arom. heavy atoms : 9
Fraction Csp3 : 0.11
Num. rotatable bonds : 0
Num. H-bond acceptors : 0.0
Num. H-bond donors : 1.0
Molar Refractivity : 50.96
TPSA : 15.79 ?2

Pharmacokinetics

GI absorption : High
BBB permeant : Yes
P-gp substrate : No
CYP1A2 inhibitor : Yes
CYP2C19 inhibitor : No
CYP2C9 inhibitor : No
CYP2D6 inhibitor : No
CYP3A4 inhibitor : No
Log Kp (skin permeation) : -5.38 cm/s

Lipophilicity

Log Po/w (iLOGP) : 2.0
Log Po/w (XLOGP3) : 3.1
Log Po/w (WLOGP) : 3.24
Log Po/w (MLOGP) : 2.61
Log Po/w (SILICOS-IT) : 3.67
Consensus Log Po/w : 2.92

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 1.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -3.7
Solubility : 0.0418 mg/ml ; 0.000199 mol/l
Class : Soluble
Log S (Ali) : -3.1
Solubility : 0.167 mg/ml ; 0.000795 mol/l
Class : Soluble
Log S (SILICOS-IT) : -4.53
Solubility : 0.00621 mg/ml ; 0.0000296 mol/l
Class : Moderately soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 1.0
Synthetic accessibility : 1.44

Safety of [ 610794-15-5 ]

Signal Word:Warning Class:
Precautionary Statements:P280 UN#:
Hazard Statements:H302-H317 Packing Group:
GHS Pictogram:

Application In Synthesis of [ 610794-15-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Upstream synthesis route of [ 610794-15-5 ]
  • Downstream synthetic route of [ 610794-15-5 ]

[ 610794-15-5 ] Synthesis Path-Upstream   1~10

  • 1
  • [ 1063613-39-7 ]
  • [ 610794-15-5 ]
YieldReaction ConditionsOperation in experiment
20% With acetic acid; zinc In water at 0 - 110℃; [2-(2-Bromo-3-methyl-6-nitro-phenyl)-vinyl]-dimethyl-amine (10 g) was dissolved in AcOH /H2O(100mL:25mL), cooled to 0°C and treated with Zn (30 g) added slowly in portions. After complete addition, the reaction mixture was heated at 110°C overnight. The mixture was diluted with water and extracted with EtOAc. The organic layer was dried over Na2S0 and concentrated to give the crude product. The crude product was purified by silica gel column chromatography to afford the title compound (1.4 g, 20 percent) 1H NMR CDCI3400 MHz δ 2.47 (m, 3H), 6.50-6.51 (m, 1H), 6.97-6.99 (m, 1 H), 7.12- 7.18(m, 2H), 8.12 (s, 1 H)
1.4 g With acetic acid; zinc In water at 0 - 110℃; 2-(2-Bromo-3-methyl-6-nitro-phenyl)vinyl]-dimethyl-amine (10 g) was dissolved in AcOH/H2O (100 mL:25 mL), cooled to 0° C. and treated with Zn (30 g) added slowly in portions. After complete addition, the reaction mixture was heated at 110° C. overnight. The mixture was diluted with water and extracted with EtOAc. The organic layer was dried over Na2SO4 and concentrated to give the crude product. The crude product was purified by silica gel column chromatography to afford the title compound (1.4 g, 20percent) 1H NMR CDCl3 400 MHz δ 2.47 (m, 3H), 6.50-6.51 (m, 1H), 6.97-6.99 (m, 1H), 7.12-7.18 (m, 2H), 8.12 (s, 1H)
Reference: [1] Patent: WO2013/117522, 2013, A1, . Location in patent: Page/Page column 38
[2] Patent: US2015/18367, 2015, A1, . Location in patent: Paragraph 0169; 0170
[3] Patent: WO2005/110416, 2005, A2, . Location in patent: Page/Page column 57
  • 2
  • [ 5815-08-7 ]
  • [ 60956-25-4 ]
  • [ 610794-15-5 ]
Reference: [1] Patent: WO2008/79918, 2008, A1, . Location in patent: Page/Page column 61-62
[2] Patent: WO2003/82826, 2003, A1, . Location in patent: Page/Page column 54
[3] Patent: WO2005/110991, 2005, A1, . Location in patent: Page/Page column 50-51
  • 3
  • [ 60956-25-4 ]
  • [ 4637-24-5 ]
  • [ 610794-15-5 ]
YieldReaction ConditionsOperation in experiment
5.5%
Stage #1: With pyrrolidine In 1,4-dioxane at 100℃; for 18 h; Inert atmosphere
Stage #2: at 110℃; for 4 h;
ep 2: A mixture of 298 (3.0 g, 13.04 mmol), pyrrolidine (926 mg, 13.04 mmol), and DMF-DMA (7.76 g, 65.22 mmol) in 1,4-dioxane (20 mL) under nitrogen atmosphere was heated at 100 °C for 18 h. The reaction was concentrated under to dryness in vacuo and to the residue was added iron (3.65 g, 65.22 mmol) and HO Ac (40 mL). The resulting mixture was heated at 110 °C for 4 h, cooled to RT and filtered. The filtrate was concentrated in vacuo. The crude was purified by S1O2 chromatography eluting with petroleum ether/EtOAc (10:1) to afford 150 mg (5.5percent) of 4-bromo-5-methyl-lH-indole (300) as a yellow solid: MS (ESI) m/z = 210.1 (M+l).
Reference: [1] Patent: WO2013/26914, 2013, A1, . Location in patent: Page/Page column 170
  • 4
  • [ 926922-44-3 ]
  • [ 610794-15-5 ]
Reference: [1] Patent: WO2007/21937, 2007, A2, . Location in patent: Page/Page column 43-44
  • 5
  • [ 60956-25-4 ]
  • [ 717111-91-6 ]
  • [ 610794-15-5 ]
Reference: [1] Patent: WO2004/43925, 2004, A2, . Location in patent: Page 68
  • 6
  • [ 576-22-7 ]
  • [ 610794-15-5 ]
Reference: [1] Patent: WO2013/26914, 2013, A1,
[2] Patent: WO2013/117522, 2013, A1,
[3] Patent: US2015/18367, 2015, A1,
[4] Patent: WO2005/110416, 2005, A2,
[5] Patent: WO2005/110991, 2005, A1,
  • 7
  • [ 7745-91-7 ]
  • [ 610794-15-5 ]
Reference: [1] Journal of Medicinal Chemistry, 1998, vol. 41, # 10, p. 1598 - 1612
  • 8
  • [ 116598-91-5 ]
  • [ 610794-15-5 ]
Reference: [1] Journal of Medicinal Chemistry, 1998, vol. 41, # 10, p. 1598 - 1612
  • 9
  • [ 60956-25-4 ]
  • [ 610794-15-5 ]
Reference: [1] Patent: WO2013/117522, 2013, A1,
[2] Patent: US2015/18367, 2015, A1,
[3] Patent: WO2005/110416, 2005, A2,
  • 10
  • [ 109179-31-9 ]
  • [ 610794-15-5 ]
Reference: [1] Patent: US2016/9706, 2016, A1,
Recommend Products
Same Skeleton Products

Technical Information

Historical Records

Related Functional Groups of
[ 610794-15-5 ]

Bromides

Chemical Structure| 52488-36-5

[ 52488-36-5 ]

4-Bromo-1H-indole

Similarity: 0.98

Chemical Structure| 885520-48-9

[ 885520-48-9 ]

4-Bromo-6-methyl-1H-indole

Similarity: 0.96

Chemical Structure| 6127-18-0

[ 6127-18-0 ]

4-Bromo-2-methyl-1H-indole

Similarity: 0.96

Chemical Structure| 99910-50-6

[ 99910-50-6 ]

4,6-Dibromo-1H-indole

Similarity: 0.96

Chemical Structure| 248602-16-6

[ 248602-16-6 ]

6-Bromo-5-methyl-1H-indole

Similarity: 0.96

Related Parent Nucleus of
[ 610794-15-5 ]

Indoles

Chemical Structure| 52488-36-5

[ 52488-36-5 ]

4-Bromo-1H-indole

Similarity: 0.98

Chemical Structure| 885520-48-9

[ 885520-48-9 ]

4-Bromo-6-methyl-1H-indole

Similarity: 0.96

Chemical Structure| 6127-18-0

[ 6127-18-0 ]

4-Bromo-2-methyl-1H-indole

Similarity: 0.96

Chemical Structure| 99910-50-6

[ 99910-50-6 ]

4,6-Dibromo-1H-indole

Similarity: 0.96

Chemical Structure| 248602-16-6

[ 248602-16-6 ]

6-Bromo-5-methyl-1H-indole

Similarity: 0.96

; ;